Showing 1 - 17 results of 17 for search 'Mathias Schreckenberger', query time: 0.06s
Refine Results
-
1
Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach by Hanane Lahnif, Tilmann Grus, Stefanie Pektor, Lukas Greifenstein, Mathias Schreckenberger, Frank Rösch
Published 2021-10-01
Article -
2
Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an <sup>18</sup>F-FDG PET/CT after COVID-19 Vaccination by Kwadwo Antwi, Federico Caobelli, Ken Kudura, Hans-Georg Buchholz, Martin Hoffmann, Mathias Schreckenberger
Published 2022-12-01
Article -
3
Cortical Binding Potential of Opioid Receptors in Patients With Fibromyalgia Syndrome and Reduced Systemic Interleukin-4 Levels – A Pilot Study by Nurcan Üçeyler, Hans-Georg Buchholz, Susanne Kewenig, Stephan-Johann Ament, Frank Birklein, Mathias Schreckenberger, Claudia Sommer
Published 2020-05-01
Article -
4
-
5
-
6
-
7
Functional Plasticity after Unilateral Vestibular Midbrain Infarction in Human Positron Emission Tomography. by Sandra Becker-Bense, Hans-Georg Buchholz, Bernhard Baier, Mathias Schreckenberger, Peter Bartenstein, Andreas Zwergal, Thomas Brandt, Marianne Dieterich
Published 2016-01-01
Article -
8
Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients by Florian Rosar, Kalle Ribbat, Martin Ries, Johannes Linxweiler, Mark Bartholomä, Stephan Maus, Mathias Schreckenberger, Samer Ezziddin, Fadi Khreish
Published 2020-05-01
Article -
9
-
10
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort by Alexander Brose, Kerstin Michalski, Juri Ruf, Marco Tosch, Susanne M. Eschmann, Mathias Schreckenberger, Jochem König, Ursula Nestle, Matthias Miederer
Published 2023-05-01
Article -
11
Value of Combined PET Imaging with [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [<sup>177</sup>Lu]Lu-PSMA-617 RLT by Fadi Khreish, Kalle Ribbat, Mark Bartholomä, Stephan Maus, Tobias Stemler, Ina Hierlmeier, Johannes Linxweiler, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Published 2021-08-01
Article -
12
Detection Efficacy of <sup>68</sup>Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience by Caroline Burgard, Manuela A. Hoffmann, Madita Frei, Hans-Georg Buchholz, Fadi Khreish, Robert J. Marlowe, Mathias Schreckenberger, Samer Ezziddin, Florian Rosar
Published 2023-02-01
Article -
13
Modeling Vestibular Compensation: Neural Plasticity Upon Thalamic Lesion by Stefan Reuss, Elena Siebrecht, Ulla Stier, Hans-Georg Buchholz, Nicole Bausbacher, Nadine Schabbach, Andrea Kronfeld, Marianne Dieterich, Marianne Dieterich, Mathias Schreckenberger
Published 2020-05-01
Article -
14
Comparison of [<sup>18</sup>F]PSMA-1007 with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse by Manuela A. Hoffmann, Finn Edler von Eyben, Nicolas Fischer, Florian Rosar, Jonas Müller-Hübenthal, Hans-Georg Buchholz, Helmut J. Wieler, Mathias Schreckenberger
Published 2022-03-01
Article -
15
-
16
Primary Staging of Prostate Cancer Patients with [<sup>18</sup>F]PSMA-1007 PET/CT Compared with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT by Manuela A. Hoffmann, Jonas Müller-Hübenthal, Florian Rosar, Nicolas Fischer, Finn Edler von Eyben, Hans-Georg Buchholz, Helmut J. Wieler, Mathias Schreckenberger
Published 2022-08-01
Article -
17
PSA and PSA Kinetics Thresholds for the Presence of <sup>68</sup>Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer by Manuela Andrea Hoffmann, Hans-Georg Buchholz, Helmut J. Wieler, Matthias Miederer, Florian Rosar, Nicolas Fischer, Jonas Müller-Hübenthal, Ludwin Trampert, Stefanie Pektor, Mathias Schreckenberger
Published 2020-02-01
Article